The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications (Q38040749)

27 August 2017

title

The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications (English)

1 reference

27 August 2017

0 references

Idit Shachar

1

1 reference

27 August 2017

Nathan Karin

series ordinal

2

1 reference

27 August 2017

publication date

4 September 2012

1 reference

Journal of Leukocyte Biology

27 August 2017

published in

1 reference

27 August 2017

volume

93

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

51-61

1 reference

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Mechanisms of foxp3+ T regulatory cell-mediated suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Multiple sclerosis (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Type I diabetes mellitus. A chronic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Rheumatoid arthritis. Pathophysiology and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Macrophages regulate induction of delayed‐type hypersensitivity and experimental allergic encephalomyelitis in SJL mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Antibody therapy for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Human CD4+ FOXP3+ regulatory T cells produce CXCL8 and recruit neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Lymphocyte homing and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Chemokines and cell migration in secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial v

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Helper T cell diversity and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

The lineage decisions of helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Effector T cell plasticity: flexibility in the face of changing circumstances

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Follicular helper CD4 T cells (TFH)

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Follicular helper T cells: lineage and location

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

T follicular helper (TFH) cells in normal and dysregulated immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Control of regulatory T cell lineage commitment and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Regulatory T cells and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Acquisition of selectin binding and peripheral homing properties by CD4(+) and CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Chemokines in tissue-specific and microenvironment-specific lymphocyte homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

The role of chemokine receptors in primary, effector, and memory immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Getting to the site of inflammation: the leukocyte adhesion cascade updated

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Immunotherapeutic approaches in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

TGF-beta: a master of all T cell trades

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Induction and effector functions of T(H)17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Transforming growth factor-beta induces development of the T(H)17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Further checkpoints in Th1 development

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Suppression of ongoing experimental autoimmune encephalomyelitis by neutralizing the function of the p28 subunit of IL-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Mast cells as "tunable" effector and immunoregulatory cells: recent advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Macrophage deactivation by interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Interleukin-10 suppression of myeloid cell activation--a continuing puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

IL-10: the master regulator of immunity to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

The biological functions of T helper 17 cell effector cytokines in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

IL-22 increases the innate immunity of tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

IL-22 mediates host defense against an intestinal intracellular parasite in the absence of IFN-γ at the cost of Th17-driven immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

A novel function of IL-2: chemokine/chemoattractant/retention receptor genes induction in Th subsets for skin and lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Interleukin-2 and regulatory T cells in graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

The activating receptor NKp46 is essential for the development of type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Interferons and their actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

The molecular cell biology of interferon-gamma and its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Lymphocyte responses and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Molecular mechanisms regulating Th1 immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Autocrine secretion of interferon gamma negatively regulates homing of immature B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Antigen-specific CD25- Foxp3- IFN-gamma(high) CD4+ T cells restrain the development of experimental allergic encephalomyelitis by suppressing Th17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Physiological and molecular mechanisms of lymphocyte homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Ly49D Receptor Expressed on Immature B Cells Regulates Their IFN-γ Secretion, Actin Polymerization, and Homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Regulation of interferon-gamma production by IL-12 and IL-18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Chemokines: immunology's high impact factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Chemokines in rapid leukocyte adhesion triggering and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

How chemokines invite leukocytes to dance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Orchestrating the orchestrators: chemokines in control of T cell traffic

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Chemotaxis of human tonsil B lymphocytes to CC chemokine receptor (CCR) 1, CCR2 and CCR4 ligands is restricted to non-germinal center cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Targeting monocyte chemoattractant protein-1 signalling in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Opportunities for novel therapeutic agents acting at chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Targeting monocyte recruitment in CNS autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

A novel recombinant fusion protein encoding a 20-amino acid residue of the third extracellular (E3) domain of CCR2 neutralizes the biological activity of CCL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Expression of the chemokine receptor CCR2 on immature B cells negatively regulates their cytoskeletal rearrangement and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

The chemokine SDF‐1, stromal cell‐derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Molecular cloning and structure of a pre-B-cell growth-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Chemokines and the arrest of lymphocytes rolling under flow conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Subsecond induction of alpha4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

The chemokine stromal cell-derived factor-1 alpha modulates alpha 4 beta 7 integrin-mediated lymphocyte adhesion to mucosal addressin cell adhesion molecule-1 and fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Canakinumab: in patients with cryopyrin-associated periodic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Anti-interleukin-12 antibody for active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0612293

21 January 2018

Identifiers

DOI

10.1189/JLB.0612293

1 reference

27 August 2017

1 reference